Allen Baharaff

Insider Reports History

Location: Tel Aviv, Israel
Signature: /s/ Allen Baharaff
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Allen Baharaff:

Form 4 holding Chief Executive Officer, Director

Galmed Pharmaceuticals Ltd.

Security class: Ordinary Shares
Shares / value: 103,047
Estimated value: $86,559
Report date: 18 Mar 2026
Price: $0.8400
Ownership: Direct

Form 4 holding Chief Executive Officer, Director

Galmed Pharmaceuticals Ltd.

Security class: Ordinary Shares
Shares / value: 18
Estimated value: $15
Report date: 18 Mar 2026
Price: $0.8400
Ownership: Indirect

Form 4 holding Chief Executive Officer, Director

Galmed Pharmaceuticals Ltd.

Security class: Restricted Share Units
Shares / value: 100,000
Estimated value
Report date: 18 Mar 2026
Price
Ownership: Direct

Insider Reports Filed by Allen Baharaff

3 GLMD

Galmed Pharmaceuticals Ltd.

Report period: 18 Mar 2026
Transactions: 0
Transaction value: $0
Filing time: 18 Mar 2026, 07:45
Role: Chief Executive Officer, Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .